ASGEN is a unique bioactive compound design and discovery company for novel pharmaceuticals, nutraceuticals and animal health products.Computer-assisted drug design uses computational chemistry to discover, enhance, or study drugs and related biologically active molecules. The most fundamental goal is to predict whether a given molecule will bind to a target and if so how strongly. Along with their pioneer character - asgen have been working on the subject for over 22 years finding out novel (lead) compounds in the following pharmacological áreas, antidiabetics, analgesics, alzheimer, oncology, neuropathic pain, radioprotectants, and many others.Our software has been validated by very important clients like Kraft, Mount Sinai, NCI, USDoD, Invitrogen, Humanetics and many more, thanks to our US partner, Medisyn Technologies Inc.